Scott D Sandell - Net Worth and Insider Trading

Scott D Sandell Net Worth

The estimated net worth of Scott D Sandell is at least $4.4 Billion dollars as of 2025-04-27. Scott D Sandell is the Director of Robinhood Markets Inc and owns about 23,850,644 shares of Robinhood Markets Inc (HOOD) stock worth over $1.2 Billion. Scott D Sandell is the 10% Owner of Tesaro Inc and owns about 10,420,645 shares of Tesaro Inc (TSRO) stock worth over $781 Million. Scott D Sandell is also the Director, 10% Owner of iShares Indl/Office Real Estate Capped and owns about 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) stock worth over $434 Million. Besides these, Scott D Sandell also holds Rhythm Pharmaceuticals Inc (RYTM) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Mirum Pharmaceuticals Inc (MIRM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Savara Inc (SVRA) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Liquidia Corp (LQDA) , MBX Biosciences Inc (MBX) , Adaptimmune Therapeutics PLC (ADAP) , Cloudflare Inc (NET) , Bloom Energy Corp (BE) , Korro Bio Inc (KRRO) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , Surface Oncology Inc (SURF) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Regulus Therapeutics Inc (RGLS) , Marker Therapeutics Inc (MRKR) , GlycoMimetics Inc (GLYC) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Metacrine Inc (MTCR) , TRACON Pharmaceuticals Inc (TCON) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) . Details can be seen in Scott D Sandell's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott D Sandell has not made any transactions after 2024-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Scott D Sandell

Scott D Sandell Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott D Sandell owns 108 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Mersana Therapeutics Inc (MRSN) among others .

Click here to see the complete history of Scott D Sandell’s form 4 insider trades.

Insider Ownership Summary of Scott D Sandell

Ticker	Company	Transaction Date	Type of Owner
EAR	Eargo Inc	2020-10-20	10 percent owner
MTCR	Metacrine Inc	2021-12-22	10 percent owner
MRSN	Mersana Therapeutics Inc	2020-04-14	10 percent owner
		2023-11-20	director & 10 percent owner
		2019-12-12	10 percent owner
		2018-07-27	director & 10 percent owner
		2020-07-28	10 percent owner
		2022-05-25	10 percent owner
		2020-07-23	10 percent owner
		2020-07-09	10 percent owner
		2021-12-15	10 percent owner
		2020-06-30	10 percent owner
		2020-06-19	10 percent owner
		2018-04-23	10 percent owner
		2016-03-17	10 percent owner
		2022-04-11	10 percent owner
		2020-04-02	10 percent owner
		2020-03-11	10 percent owner
		2015-03-11	10 percent owner
		2020-02-06	10 percent owner
		2020-01-29	10 percent owner
		2020-01-24	10 percent owner
		2020-12-04	10 percent owner
		2019-11-26	10 percent owner
		2019-11-06	10 percent owner
		2019-10-30	10 percent owner
		2019-07-22	10 percent owner
		2019-06-07	10 percent owner
		2019-01-22	10 percent owner
		2018-12-07	10 percent owner
		2018-10-17	10 percent owner
		2021-03-16	10 percent owner
		2018-10-04	10 percent owner
		2018-07-30	10 percent owner
		2023-01-26	10 percent owner
		2018-05-01	10 percent owner
		2018-03-27	10 percent owner
		2018-03-09	10 percent owner
		2018-02-26	10 percent owner
		2018-02-26	10 percent owner
		2017-11-27	10 percent owner
		2015-09-30	10 percent owner
		2018-01-01	10 percent owner
		2017-11-20	10 percent owner
		2017-11-06	10 percent owner
		2017-10-10	10 percent owner
		2015-01-26	10 percent owner
		2016-12-19	10 percent owner
		2016-09-21	10 percent owner
		2016-07-29	10 percent owner
		2016-06-14	10 percent owner
		2016-02-03	10 percent owner
		2016-01-12	10 percent owner
		2015-06-17	10 percent owner
		2015-10-14	10 percent owner
		2015-07-01	10 percent owner
		2015-01-22	10 percent owner
		2014-12-19	10 percent owner
		2014-01-30	10 percent owner
		2014-12-05	director
		2014-11-25	10 percent owner
		2014-10-08	10 percent owner
		2014-08-27	10 percent owner
		2014-08-06	10 percent owner
		2014-04-02	10 percent owner
		2014-02-28	director & 10 percent owner
		2013-05-22	10 percent owner
		2013-12-05	10 percent owner
		2013-10-29	10 percent owner
		2013-08-15	10 percent owner
		2011-11-21	10 percent owner
		2012-10-29	10 percent owner
		2012-03-28	10 percent owner
		2007-05-30	10 percent owner
		2009-10-01	10 percent owner
		2011-08-08	10 percent owner
		2006-05-23	10 percent owner
		2011-03-10	10 percent owner
		2010-06-23	10 percent owner
		2009-05-08	10 percent owner
		2009-02-20	10 percent owner
		2006-05-09	10 percent owner
		2003-12-31	10 percent owner
		2009-04-03	10 percent owner
		2023-07-17	10 percent owner
		2021-06-29	10 percent owner
		2016-02-10	10 percent owner
		2021-10-21	10 percent owner
		2018-12-07	10 percent owner
		2021-04-08	10 percent owner
		2021-03-30	director & 10 percent owner
		2021-01-01	10 percent owner
		2021-06-24	10 percent owner
		2020-12-09	10 percent owner
		2022-05-12	director & 10 percent owner
		2022-12-23	10 percent owner
		2021-07-21	10 percent owner
		2021-09-30	10 percent owner
		2021-06-23	10 percent owner
		2021-12-03	10 percent owner
		2022-06-08	10 percent owner
		2022-08-03	10 percent owner
		2016-02-10	10 percent owner
		2020-03-11	10 percent owner
		2018-01-19	10 percent owner
		2023-07-13	10 percent owner
		2021-07-21	10 percent owner
		2024-04-22	10 percent owner

Scott D Sandell Latest Holdings Summary

Scott D Sandell currently owns a total of 45 stocks. Among these stocks, Scott D Sandell owns 23,850,644 shares of Robinhood Markets Inc (HOOD) as of May 12, 2022, with a value of $1.2 Billion and a weighting of 26.77%. Scott D Sandell owns 10,420,645 shares of Tesaro Inc (TSRO) as of March 6, 2018, with a value of $781 Million and a weighting of 17.73%. Scott D Sandell also owns 13,605,419 shares of iShares Indl/Office Real Estate Capped (FNIO) as of April 30, 2012, with a value of $434 Million and a weighting of 9.85%. The other 42 stocks Rhythm Pharmaceuticals Inc (RYTM) , Arcellx Inc (ACLX) , Supernus Pharmaceuticals Inc (SUPN) , Mirum Pharmaceuticals Inc (MIRM) , Ra Pharmaceuticals Inc (RARX) , Echo Global Logistics Inc (ECHO) , Savara Inc (SVRA) , Groupon Inc (GRPN) , Trevi Therapeutics Inc (TRVI) , Boingo Wireless Inc (WIFI) , AVEO Pharmaceuticals Inc (AVEO) , Akouos Inc (AKUS) , Ardelyx Inc (ARDX) , Liquidia Corp (LQDA) , MBX Biosciences Inc (MBX) , Adaptimmune Therapeutics PLC (ADAP) , Cloudflare Inc (NET) , Bloom Energy Corp (BE) , Korro Bio Inc (KRRO) , InnerWorkings Inc (INWK) , Millennial Media Inc (MM) , Tableau Software Inc (DATA) , Epizyme Inc (EPZM) , Surface Oncology Inc (SURF) , Mersana Therapeutics Inc (MRSN) , Inozyme Pharma Inc (INZY) , Regulus Therapeutics Inc (RGLS) , Marker Therapeutics Inc (MRKR) , GlycoMimetics Inc (GLYC) , Workday Inc (WDAY) , Eargo Inc (EAR) , Catalyst Biosciences Inc (CBIO) , Dermira Inc (DERM) , Interleukin Genetics Inc (ILIU) , Achaogen Inc (AKAOQ) , Clovis Oncology Inc (CLVSQ) , Metacrine Inc (MTCR) , TRACON Pharmaceuticals Inc (TCON) , Novation Companies Inc (NOVCQ) , ARCA biopharma Inc (ABIO) , Genocea Biosciences Inc (GNCAQ) , Appian Corp (APPN) have a combined weighting of 45.65% among all his current holdings.

Latest Holdings of Scott D Sandell

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HOOD	Robinhood Markets Inc	2022-05-12	23,850,644	49.45	1,179,414,346
TSRO	Tesaro Inc	2018-03-06	10,420,645	74.96	781,131,549
FNIO	iShares Indl/Office Real Estate Capped	2012-04-30	13,605,419	31.89	433,876,812
RYTM	Rhythm Pharmaceuticals Inc	2017-10-10	4,909,956	63.76	313,058,795
ACLX	Arcellx Inc	2022-12-23	4,746,494	63.71	302,399,133
SUPN	Supernus Pharmaceuticals Inc	2015-06-17	7,641,250	32.22	246,201,075
MIRM	Mirum Pharmaceuticals Inc	2019-07-22	4,186,243	40.80	170,798,714
RARX	Ra Pharmaceuticals Inc	2016-10-31	3,490,073	47.99	167,488,603
ECHO	Echo Global Logistics Inc	2009-10-01	2,420,219	48.24	116,751,365
SVRA	Savara Inc	2023-07-17	24,471,264	3.18	77,818,620
GRPN	Groupon Inc	2013-08-15	3,709,248	19.89	73,776,943
TRVI	Trevi Therapeutics Inc	2022-04-11	11,370,376	6.47	73,566,333
WIFI	Boingo Wireless Inc	2013-12-11	4,467,960	13.99	62,506,760
AVEO	AVEO Pharmaceuticals Inc	2020-06-19	3,952,958	15.00	59,294,370
AKUS	Akouos Inc	2020-06-30	4,294,207	13.29	57,070,011
ARDX	Ardelyx Inc	2021-12-15	10,752,106	5.26	56,556,078
LQDA	Liquidia Corp	2018-07-30	2,484,870	14.12	35,086,364
MBX	MBX Biosciences Inc	2024-09-16	3,614,486	9.17	33,144,837
ADAP	Adaptimmune Therapeutics PLC	2020-01-24	102,478,668	0.27	27,187,591
NET	Cloudflare Inc	2023-11-20	217,859	121.00	26,360,939
BE	Bloom Energy Corp	2018-07-27	1,333,333	18.93	25,239,994
KRRO	Korro Bio Inc	2024-04-22	1,090,793	18.09	19,732,445
INWK	InnerWorkings Inc	2012-02-29	6,029,190	2.99	18,027,278
MM	Millennial Media Inc	2012-10-29	8,196,614	1.75	14,344,075
DATA	Tableau Software Inc	2014-12-05	55,705	169.53	9,443,669
EPZM	Epizyme Inc	2016-01-12	6,261,502	1.47	9,204,408
SURF	Surface Oncology Inc	2018-04-23	3,312,877	1.07	3,544,778
MRSN	Mersana Therapeutics Inc	2020-04-14	7,959,520	0.36	2,896,469
INZY	Inozyme Pharma Inc	2020-07-28	2,437,689	0.98	2,399,174
RGLS	Regulus Therapeutics Inc	2020-12-04	645,106	2.76	1,780,493
MRKR	Marker Therapeutics Inc	2021-03-16	1,071,429	1.25	1,339,286
GLYC	GlycoMimetics Inc	2023-01-26	4,967,530	0.26	1,296,525
WDAY	Workday Inc	2014-02-28	5,088	239.53	1,218,729
EAR	Eargo Inc	2020-10-20	326,001	2.57	837,823
CBIO	Catalyst Biosciences Inc	2013-12-05	43,462	7.67	333,332
DERM	Dermira Inc	2014-10-02	17,241	18.75	323,269
ILIU	Interleukin Genetics Inc	2016-07-29	55,418,811	0.00	249,385
AKAOQ	Achaogen Inc	2016-12-19	5,215,128	0.03	130,378
CLVSQ	Clovis Oncology Inc	2011-11-21	3,419,671	0.02	51,295
MTCR	Metacrine Inc	2021-12-22	2,563,257	0.00	3,589
TCON	TRACON Pharmaceuticals Inc	2018-03-27	17,330	0.03	558
NOVCQ	Novation Companies Inc	2006-05-15	1,225,179	0.00	123
ABIO	ARCA biopharma Inc	2018-02-26	0	25.50	0
GNCAQ	Genocea Biosciences Inc	2022-05-25	0	0.00	0
APPN	Appian Corp	2017-11-27	0	31.32	0

Holding Weightings of Scott D Sandell

Scott D Sandell Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott D Sandell has made a total of 3 transactions in Robinhood Markets Inc (HOOD) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Robinhood Markets Inc is the sale of 8,792 shares on May 12, 2022, which brought Scott D Sandell around $73,941.

According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in Tesaro Inc (TSRO) over the past 5 years. The most-recent trade in Tesaro Inc is the acquisition of 145,532 shares on March 6, 2018, which cost Scott D Sandell around $8 Million.

According to the SEC Form 4 filings, Scott D Sandell has made a total of 0 transactions in iShares Indl/Office Real Estate Capped (FNIO) over the past 5 years. The most-recent trade in iShares Indl/Office Real Estate Capped is the sale of 20,249 shares on April 30, 2012, which brought Scott D Sandell around $535,586.

More details on Scott D Sandell's insider transactions can be found in the Insider Trading History of Scott D Sandell table.

Insider Trading History of Scott D Sandell

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott D Sandell Trading Performance

GuruFocus tracks the stock performance after each of Scott D Sandell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Scott D Sandell is 7.06%. GuruFocus also compares Scott D Sandell's trading performance to market benchmark return within the same time period. The performance of stocks bought by Scott D Sandell within 3 months outperforms 32 times out of 59 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Scott D Sandell's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Scott D Sandell

Average Return

Average return per transaction

Outperforming Transactions

14 out of 57 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	5.84
Relative Return to S&P 500(%)	4.87

Scott D Sandell Ownership Network

Ownership Network List of Scott D Sandell

No Data

Ownership Network Relation of Scott D Sandell

Scott D Sandell Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Scott D Sandell is the 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Eargo Inc Insider Transactions

No Available Data

What does Metacrine Inc do?

Who are the key executives at Metacrine Inc?

Scott D Sandell is the 10 percent owner of Metacrine Inc. Other key executives at Metacrine Inc include Chief Business Officer Michael York , director & President & CEO Preston Klassen , and 10 percent owner Braden Michael Leonard .

Metacrine Inc (MTCR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Metacrine Inc (MTCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Metacrine Inc Insider Transactions

No Available Data

What does Mersana Therapeutics Inc do?

Who are the key executives at Mersana Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Mersana Therapeutics Inc. Other key executives at Mersana Therapeutics Inc include director & President and CEO Anna Protopapas , SVP & Chief Development Officer Mohan Bala , and Sr. VP & Finance & Product stgy Brian Deschuytner .

Mersana Therapeutics Inc (MRSN) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Mersana Therapeutics Inc (MRSN). Other recent insider transactions involving Mersana Therapeutics Inc (MRSN) include a net sale of 37,528 shares made by Brian Deschuytner , a net sale of 37,421 shares made by Timothy B Lowinger , and a net sale of 28,194 shares made by Mohan Bala .

In summary, during the past 3 months, insiders sold 0 shares of Mersana Therapeutics Inc (MRSN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 264,237 shares of Mersana Therapeutics Inc (MRSN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 264,237 shares.

Mersana Therapeutics Inc (MRSN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mersana Therapeutics Inc Insider Transactions

No Available Data

What does Cloudflare Inc do?

Who are the key executives at Cloudflare Inc?

Scott D Sandell is the director & 10 percent owner of Cloudflare Inc. Other key executives at Cloudflare Inc include director & Chief Operating Officer Michelle Zatlyn , director & 10 percent owner & CEO and Chair of the Board Matthew Prince , and General Counsel Douglas James Kramer .

Cloudflare Inc (NET) Insider Trades Summary

Over the past 18 months, Scott D Sandell made 1 insider transaction in Cloudflare Inc (NET) with a net sale of 211,534. Other recent insider transactions involving Cloudflare Inc (NET) include a net sale of 819,342 shares made by Thomas J Seifert , a net sale of 641,059 shares made by Carl Ledbetter , and a net sale of 2,828,736 shares made by Matthew Prince .

In summary, during the past 3 months, insiders sold 809,059 shares of Cloudflare Inc (NET) in total and bought 0 shares, with a net sale of 809,059 shares. During the past 18 months, 6,359,879 shares of Cloudflare Inc (NET) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,359,879 shares.

Cloudflare Inc (NET)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cloudflare Inc Insider Transactions

No Available Data

What does Sprout Social Inc do?

Who are the key executives at Sprout Social Inc?

Scott D Sandell is the 10 percent owner of Sprout Social Inc. Other key executives at Sprout Social Inc include President Ryan Paul Barretto , director & 10 percent owner & Chairman and CEO Justyn Russell Howard , and CFO and Treasurer Preto Joseph Del .

Sprout Social Inc (SPT) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Sprout Social Inc (SPT). Other recent insider transactions involving Sprout Social Inc (SPT) include a net sale of 568,595 shares made by Justyn Russell Howard , a net sale of 39,679 shares made by Preto Joseph Del , and a net sale of 201,006 shares made by Ryan Paul Barretto .

In summary, during the past 3 months, insiders sold 169,879 shares of Sprout Social Inc (SPT) in total and bought 0 shares, with a net sale of 169,879 shares. During the past 18 months, 1,061,490 shares of Sprout Social Inc (SPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,061,490 shares.

Sprout Social Inc (SPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sprout Social Inc Insider Transactions

No Available Data

What does Bloom Energy Corp do?

Who are the key executives at Bloom Energy Corp?

Scott D Sandell is the director & 10 percent owner of Bloom Energy Corp. Other key executives at Bloom Energy Corp include director & Chairman & CEO Kr Sridhar , EVP & GC & Secretary Shawn Marie Soderberg , and EVP & Sales - Americas Guillermo Brooks .

Bloom Energy Corp (BE) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Bloom Energy Corp (BE). Other recent insider transactions involving Bloom Energy Corp (BE) include a net sale of 54,155 shares made by Shawn Marie Soderberg , a net sale of 13,971 shares made by , and a net sale of 246,503 shares made by Kr Sridhar .

In summary, during the past 3 months, insiders sold 75,329 shares of Bloom Energy Corp (BE) in total and bought 0 shares, with a net sale of 75,329 shares. During the past 18 months, 381,818 shares of Bloom Energy Corp (BE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 381,818 shares.

Bloom Energy Corp (BE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bloom Energy Corp Insider Transactions

No Available Data

What does Inozyme Pharma Inc do?

Who are the key executives at Inozyme Pharma Inc?

Scott D Sandell is the 10 percent owner of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and 10 percent owner Longitude Capital Partners Iii, Llc .

Inozyme Pharma Inc (INZY) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net sale of 16,342 shares made by Douglas A Treco ,

In summary, during the past 3 months, insiders sold 8,819 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 8,819 shares. During the past 18 months, 16,342 shares of Inozyme Pharma Inc (INZY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,342 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inozyme Pharma Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Scott D Sandell is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .

Genocea Biosciences Inc (GNCAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Annexon Inc do?

Who are the key executives at Annexon Inc?

Scott D Sandell is the 10 percent owner of Annexon Inc. Other key executives at Annexon Inc include EVP & Chief Scientific Officer Dean Richard Artis , EVP & Chief Financial Officer Jennifer Lew , and EVP & Chief Innovation Officer Ted Yednock .

Annexon Inc (ANNX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Annexon Inc (ANNX). Other recent insider transactions involving Annexon Inc (ANNX) include a net sale of 85,113 shares made by Ted Yednock , a net purchase of 25,600 shares made by William H. Carson , and a net sale of 14,204 shares made by Jennifer Lew .

In summary, during the past 3 months, insiders sold 42,926 shares of Annexon Inc (ANNX) in total and bought 0 shares, with a net sale of 42,926 shares. During the past 18 months, 133,283 shares of Annexon Inc (ANNX) were sold and 375,600 shares were bought by its insiders, resulting in a net purchase of 242,317 shares.

Annexon Inc (ANNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Annexon Inc Insider Transactions

No Available Data

What does Nkarta Inc do?

Who are the key executives at Nkarta Inc?

Scott D Sandell is the 10 percent owner of Nkarta Inc. Other key executives at Nkarta Inc include See Remarks Alyssa Levin , Chief Medical Officer David Shook , and Chief Legal Officer Alicia J. Hager .

Nkarta Inc (NKTX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Nkarta Inc (NKTX). Other recent insider transactions involving Nkarta Inc (NKTX) include a net sale of 18,261 shares made by Alicia J. Hager , a net sale of 28,845 shares made by Paul J Hastings , and a net sale of 12,646 shares made by David Shook .

In summary, during the past 3 months, insiders sold 0 shares of Nkarta Inc (NKTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 84,937 shares of Nkarta Inc (NKTX) were sold and 5,000,000 shares were bought by its insiders, resulting in a net purchase of 4,915,063 shares.

Nkarta Inc (NKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nkarta Inc Insider Transactions

No Available Data

What does Ardelyx Inc do?

Who are the key executives at Ardelyx Inc?

Scott D Sandell is the 10 percent owner of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , Chief Medical Officer Laura A Williams , and Chief Financial Officer Justin A Renz .

Ardelyx Inc (ARDX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Ardelyx Inc (ARDX). Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 575,904 shares made by Michael Raab , a net sale of 296,606 shares made by David P. Rosenbaum , and a net sale of 497,339 shares made by Elizabeth A Grammer .

In summary, during the past 3 months, insiders sold 162,367 shares of Ardelyx Inc (ARDX) in total and bought 77,729 shares, with a net sale of 84,638 shares. During the past 18 months, 2,163,194 shares of Ardelyx Inc (ARDX) were sold and 705,897 shares were bought by its insiders, resulting in a net sale of 1,457,297 shares.

Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ardelyx Inc Insider Transactions

No Available Data

What does Akouos Inc do?

Who are the key executives at Akouos Inc?

Scott D Sandell is the 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .

Akouos Inc (AKUS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akouos Inc Insider Transactions

No Available Data

What does AVEO Pharmaceuticals Inc do?

Who are the key executives at AVEO Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of AVEO Pharmaceuticals Inc. Other key executives at AVEO Pharmaceuticals Inc include Chief Operating Officer Jebediah Ledell , director & President & CEO Michael P Bailey , and Chief Commercial Officer Michael Ferraresso .

AVEO Pharmaceuticals Inc (AVEO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

AVEO Pharmaceuticals Inc Insider Transactions

No Available Data

What does Surface Oncology Inc do?

Who are the key executives at Surface Oncology Inc?

Scott D Sandell is the 10 percent owner of Surface Oncology Inc. Other key executives at Surface Oncology Inc include Deputy GC Chandra Adams , Chief Medical Officer Alison Oneill , and See Remarks Jessica Fees .

Surface Oncology Inc (SURF) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Surface Oncology Inc (SURF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Surface Oncology Inc (SURF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Surface Oncology Inc (SURF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Surface Oncology Inc Insider Transactions

No Available Data

What does Senseonics Holdings Inc do?

Who are the key executives at Senseonics Holdings Inc?

Scott D Sandell is the 10 percent owner of Senseonics Holdings Inc. Other key executives at Senseonics Holdings Inc include Chief Financial Officer Frederick T. Sullivan , director & President & Chief Exec Officer Timothy T Goodnow , and VP Operations & Qual & Reg Mukul Jain .

Senseonics Holdings Inc (SENS) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Senseonics Holdings Inc (SENS). Other recent insider transactions involving Senseonics Holdings Inc (SENS) include a net purchase of 400,000 shares made by Douglas A Roeder , a net purchase of 315,000 shares made by Timothy T Goodnow , and a net purchase of 124,933 shares made by Frederick T. Sullivan .

In summary, during the past 3 months, insiders sold 0 shares of Senseonics Holdings Inc (SENS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Senseonics Holdings Inc (SENS) were sold and 839,933 shares were bought by its insiders, resulting in a net purchase of 839,933 shares.

Senseonics Holdings Inc (SENS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senseonics Holdings Inc Insider Transactions

No Available Data

What does Trevi Therapeutics Inc do?

Who are the key executives at Trevi Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Trevi Therapeutics Inc. Other key executives at Trevi Therapeutics Inc include 10 percent owner & Chief Medical Officer Thomas Sciascia , director & 10 percent owner & See Remarks Jennifer L Good , and Chief Commercial Officer Farrell Simon .

Trevi Therapeutics Inc (TRVI) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Trevi Therapeutics Inc (TRVI). Other recent insider transactions involving Trevi Therapeutics Inc (TRVI) include a net sale of 96,058 shares made by Jennifer L Good , a net sale of 104,000 shares made by Thomas Sciascia , and a net sale of 81,313 shares made by Farrell Simon .

In summary, during the past 3 months, insiders sold 89,207 shares of Trevi Therapeutics Inc (TRVI) in total and bought 0 shares, with a net sale of 89,207 shares. During the past 18 months, 290,276 shares of Trevi Therapeutics Inc (TRVI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 290,276 shares.

Trevi Therapeutics Inc (TRVI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevi Therapeutics Inc Insider Transactions

No Available Data

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & President and CEO Douglas A Treco , and 10 percent owner Forest Baskett .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

What does Imara Inc do?

Who are the key executives at Imara Inc?

Scott D Sandell is the 10 percent owner of Imara Inc. Other key executives at Imara Inc include director & President & CEO Rahul D. Ballal , See Remarks Michael Gray , and 10 percent owner Braden Michael Leonard .

Imara Inc (IMRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Imara Inc (IMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Imara Inc (IMRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Imara Inc (IMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Imara Inc Insider Transactions

No Available Data

What does Champions Oncology Inc do?

Who are the key executives at Champions Oncology Inc?

Scott D Sandell is the 10 percent owner of Champions Oncology Inc. Other key executives at Champions Oncology Inc include director & President Ronnie Morris , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Roger H Lee .

Champions Oncology Inc (CSBR) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Champions Oncology Inc (CSBR). Other recent insider transactions involving Champions Oncology Inc (CSBR) include a net purchase of 25,044 shares made by Daniel Newman Mendelson ,

In summary, during the past 3 months, insiders sold 0 shares of Champions Oncology Inc (CSBR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Champions Oncology Inc (CSBR) were sold and 25,044 shares were bought by its insiders, resulting in a net purchase of 25,044 shares.

Champions Oncology Inc (CSBR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Champions Oncology Inc Insider Transactions

No Available Data

What does Casper Sleep Inc do?

Who are the key executives at Casper Sleep Inc?

Scott D Sandell is the 10 percent owner of Casper Sleep Inc. Other key executives at Casper Sleep Inc include Chief Financial Officer Michael P. Monahan , director & Chief Strategy Officer Neil Parikh , and CCO & President Emilie Arel .

Casper Sleep Inc (CSPR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Casper Sleep Inc (CSPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Casper Sleep Inc (CSPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Casper Sleep Inc (CSPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Casper Sleep Inc Insider Transactions

No Available Data

What does Black Diamond Therapeutics Inc do?

Who are the key executives at Black Diamond Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Black Diamond Therapeutics Inc. Other key executives at Black Diamond Therapeutics Inc include 10 percent owner Biotech Growth N V , 10 percent owner Versant Venture Capital Vi, L.p. , and director & 10 percent owner Ali Behbahani .

Black Diamond Therapeutics Inc (BDTX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Black Diamond Therapeutics Inc (BDTX). Other recent insider transactions involving Black Diamond Therapeutics Inc (BDTX) include a net sale of 5,784,292 shares made by Biotech Growth N V , and a net sale of 221,600 shares made by Versant Venture Capital Vi, L.p. .

In summary, during the past 3 months, insiders sold 5,784,292 shares of Black Diamond Therapeutics Inc (BDTX) in total and bought 0 shares, with a net sale of 5,784,292 shares. During the past 18 months, 6,005,892 shares of Black Diamond Therapeutics Inc (BDTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,005,892 shares.

Black Diamond Therapeutics Inc (BDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Black Diamond Therapeutics Inc Insider Transactions

No Available Data

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Scott D Sandell is the 10 percent owner of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Medical Officer Elliot Norry , Chief Operating Officer Bertrand William C Jr , and Chief Patient Supply Officer John Lunger .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 158,756 shares made by Adrian Rawcliffe , a net sale of 60,150 shares made by Elliot Norry , and a net sale of 57,944 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 371,522 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 371,522 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

What does Regulus Therapeutics Inc do?

Who are the key executives at Regulus Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Regulus Therapeutics Inc. Other key executives at Regulus Therapeutics Inc include Chief Operating Officer Joseph P Hagan , Sr. VP & General Counsel Christopher Ray Aker , and Chief Financial Officer Crispina Calsada .

Regulus Therapeutics Inc (RGLS) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Regulus Therapeutics Inc (RGLS). Other recent insider transactions involving Regulus Therapeutics Inc (RGLS) include a net sale of 91,634 shares made by Joseph P Hagan , a net sale of 49,272 shares made by Crispina Calsada , and a net sale of 49,103 shares made by Christopher Ray Aker .

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc (RGLS) in total and bought 69,610 shares, with a net purchase of 69,610 shares. During the past 18 months, 271,454 shares of Regulus Therapeutics Inc (RGLS) were sold and 73,610 shares were bought by its insiders, resulting in a net sale of 197,844 shares.

Regulus Therapeutics Inc (RGLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regulus Therapeutics Inc Insider Transactions

No Available Data

What does Proteostasis Therapeutics Inc do?

Who are the key executives at Proteostasis Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .

Proteostasis Therapeutics Inc (PTI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Proteostasis Therapeutics Inc Insider Transactions

No Available Data

What does Galera Therapeutics Inc do?

Who are the key executives at Galera Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include director & President and CEO Mel Sorensen , Chief Commercial Officer Mark Bachleda , and Chief Financial Officer Chris Degnan .

Galera Therapeutics Inc (GRTX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 3,712,809 shares made by , a net purchase of 7,644,932 shares made by Nancy T Chang , and a net sale of 67,015 shares made by Mel Sorensen .

In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 67,015 shares of Galera Therapeutics Inc (GRTX) were sold and 11,357,741 shares were bought by its insiders, resulting in a net purchase of 11,290,726 shares.

Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galera Therapeutics Inc Insider Transactions

No Available Data

What does Oyster Point Pharma Inc do?

Who are the key executives at Oyster Point Pharma Inc?

Scott D Sandell is the 10 percent owner of Oyster Point Pharma Inc. Other key executives at Oyster Point Pharma Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & 10 percent owner Link William J Phd , and Chief Commercial Officer John Snisarenko .

Oyster Point Pharma Inc (OYST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oyster Point Pharma Inc (OYST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oyster Point Pharma Inc (OYST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oyster Point Pharma Inc (OYST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Oyster Point Pharma Inc Insider Transactions

No Available Data

What does Mirum Pharmaceuticals Inc do?

Who are the key executives at Mirum Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Mirum Pharmaceuticals Inc. Other key executives at Mirum Pharmaceuticals Inc include SVP & Global Controller Jolanda Howe , Chief Operating Officer Peter Radovich , and director & President and CEO Christopher Peetz .

Mirum Pharmaceuticals Inc (MIRM) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Mirum Pharmaceuticals Inc (MIRM). Other recent insider transactions involving Mirum Pharmaceuticals Inc (MIRM) include a net sale of 69,375 shares made by Jolanda Howe , a net sale of 38,032 shares made by Peter Radovich , and a net sale of 101,929 shares made by Christopher Peetz .

In summary, during the past 3 months, insiders sold 162,822 shares of Mirum Pharmaceuticals Inc (MIRM) in total and bought 6,364 shares, with a net sale of 156,458 shares. During the past 18 months, 256,352 shares of Mirum Pharmaceuticals Inc (MIRM) were sold and 13,619 shares were bought by its insiders, resulting in a net sale of 242,733 shares.

Mirum Pharmaceuticals Inc (MIRM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Mirum Pharmaceuticals Inc Insider Transactions

No Available Data

What does Nightstar Therapeutics PLC do?

Who are the key executives at Nightstar Therapeutics PLC?

Scott D Sandell is the 10 percent owner of Nightstar Therapeutics PLC. Other key executives at Nightstar Therapeutics PLC include 10 percent owner Peter J Barris , director & 10 percent owner David M Mott , and 10 percent owner Joshua Makower .

Nightstar Therapeutics PLC (NITE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nightstar Therapeutics PLC (NITE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nightstar Therapeutics PLC (NITE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nightstar Therapeutics PLC (NITE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nightstar Therapeutics PLC Insider Transactions

No Available Data

What does Tesaro Inc do?

Who are the key executives at Tesaro Inc?

Scott D Sandell is the 10 percent owner of Tesaro Inc. Other key executives at Tesaro Inc include director & President & COO Mary Lynne Hedley , SVP & Chief Medical Officer Huber Martin H. Jr. , and director & Chief Executive Officer Moulder Leon O Jr .

Tesaro Inc (TSRO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tesaro Inc (TSRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tesaro Inc (TSRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tesaro Inc (TSRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tesaro Inc Insider Transactions

No Available Data

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include General Counsel and Secretary Tamara L Joseph , Chief Financial Officer Arcudi Iii Louis J , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millendo Therapeutics Inc Insider Transactions

No Available Data

What does PhaseBio Pharmaceuticals Inc do?

Who are the key executives at PhaseBio Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .

PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

PhaseBio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Marker Therapeutics Inc do?

Who are the key executives at Marker Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include 10 percent owner New Enterprise Associates 16, L.p. , Interim CFO Eliot M Lurier , and 10 percent owner Carmen Chang .

Marker Therapeutics Inc (MRKR) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Marker Therapeutics Inc (MRKR). Other recent insider transactions involving Marker Therapeutics Inc (MRKR) include a net purchase of 554,250 shares made by New Enterprise Associates 16, L.p. , and a net purchase of 11,085 shares made by Steve Elms .

In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 565,335 shares were bought by its insiders, resulting in a net purchase of 565,335 shares.

Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marker Therapeutics Inc Insider Transactions

No Available Data

What does Elastic NV do?

Who are the key executives at Elastic NV?

Scott D Sandell is the 10 percent owner of Elastic NV. Other key executives at Elastic NV include Chief Executive Officer Ashutosh Kulkarni , Chief Legal Officer Carolyn Herzog , and Chief Product Officer Ken Exner .

Elastic NV (ESTC) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Elastic NV (ESTC). Other recent insider transactions involving Elastic NV (ESTC) include a net sale of 1,333,318 shares made by Shay Banon , a net sale of 135,675 shares made by Ashutosh Kulkarni , and a net sale of 59,743 shares made by Carolyn Herzog .

In summary, during the past 3 months, insiders sold 240,630 shares of Elastic NV (ESTC) in total and bought 0 shares, with a net sale of 240,630 shares. During the past 18 months, 4,811,719 shares of Elastic NV (ESTC) were sold and 20,000 shares were bought by its insiders, resulting in a net sale of 4,791,719 shares.

Elastic NV (ESTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Elastic NV Insider Transactions

No Available Data

What does Liquidia Corp do?

Who are the key executives at Liquidia Corp?

Scott D Sandell is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include Chief Medical Officer Rajeev Saggar , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .

Liquidia Corp (LQDA) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 20,348 shares made by Jason Adair , a net sale of 48,578 shares made by Rajeev Saggar , and a net sale of 25,242 shares made by Scott Moomaw .

In summary, during the past 3 months, insiders sold 39,803 shares of Liquidia Corp (LQDA) in total and bought 0 shares, with a net sale of 39,803 shares. During the past 18 months, 432,318 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,591,073 shares.

Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Liquidia Corp Insider Transactions

No Available Data

What does GlycoMimetics Inc do?

Who are the key executives at GlycoMimetics Inc?

Scott D Sandell is the 10 percent owner of GlycoMimetics Inc. Other key executives at GlycoMimetics Inc include 10 percent owner Invus Public Equities, L.p. , Chief Medical Officer Edwin Rock , and CFO Brian M. Hahn .

GlycoMimetics Inc (GLYC) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in GlycoMimetics Inc (GLYC). Other recent insider transactions involving GlycoMimetics Inc (GLYC) include a net sale of 2,271,499 shares made by Invus Public Equities, L.p. , a net purchase of 305,000 shares made by Edwin Rock , and a net purchase of 17,500 shares made by Brian M. Hahn .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc (GLYC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,271,499 shares of GlycoMimetics Inc (GLYC) were sold and 322,500 shares were bought by its insiders, resulting in a net sale of 1,948,999 shares.

GlycoMimetics Inc (GLYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

GlycoMimetics Inc Insider Transactions

No Available Data

What does MuleSoft Inc do?

Who are the key executives at MuleSoft Inc?

Scott D Sandell is the 10 percent owner of MuleSoft Inc. Other key executives at MuleSoft Inc include 10 percent owner M James Barrett , 10 percent owner New Enterprise Associates 14, L.p. , and 10 percent owner Patrick J Kerins .

MuleSoft Inc (MULE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MuleSoft Inc (MULE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MuleSoft Inc (MULE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MuleSoft Inc (MULE)'s detailed insider trading history can be found in Insider Trading Tracker table.

MuleSoft Inc Insider Transactions

No Available Data

What does TRACON Pharmaceuticals Inc do?

Who are the key executives at TRACON Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of TRACON Pharmaceuticals Inc. Other key executives at TRACON Pharmaceuticals Inc include 10 percent owner Opaleye Management Inc. , director & President and CEO Charles Theuer , and Chief Operating Officer Bonne J. Adams .

TRACON Pharmaceuticals Inc (TCON) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in TRACON Pharmaceuticals Inc (TCON). Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net sale of 4,764,008 shares made by Opaleye Management Inc. ,

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 238,200 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 0 shares were bought by its insiders, resulting in a net sale of 238,200 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

TRACON Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cascadian Therapeutics Inc do?

Who are the key executives at Cascadian Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Cascadian Therapeutics Inc. Other key executives at Cascadian Therapeutics Inc include 10 percent owner Nea Partners 15, L.p. , 10 percent owner Jon Sakoda , and 10 percent owner Florence Anthony A. Jr. .

Cascadian Therapeutics Inc (CASC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc (CASC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc (CASC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc (CASC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cascadian Therapeutics Inc Insider Transactions

No Available Data

What does ARCA biopharma Inc do?

Who are the key executives at ARCA biopharma Inc?

Scott D Sandell is the 10 percent owner of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .

ARCA biopharma Inc (ABIO) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.

ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARCA biopharma Inc Insider Transactions

No Available Data

What does Tintri Inc do?

Who are the key executives at Tintri Inc?

Scott D Sandell is the 10 percent owner of Tintri Inc. Other key executives at Tintri Inc include director & Chairman & CEO Kenneth Klein , 10 percent owner Insight Venture Associates Viii, Ltd. , and 10 percent owner Insight Venture Associates Viii, L.p. .

Tintri Inc (TNTRQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tintri Inc (TNTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tintri Inc (TNTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tintri Inc (TNTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tintri Inc Insider Transactions

No Available Data

What does Appian Corp do?

Who are the key executives at Appian Corp?

Scott D Sandell is the 10 percent owner of Appian Corp. Other key executives at Appian Corp include 10 percent owner Abdiel Qualified Master Fund Lp , director & 10 percent owner Biddle Albert G.w. Iii , and Chief Revenue Officer Christopher M Jones .

Appian Corp (APPN) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Appian Corp (APPN). Other recent insider transactions involving Appian Corp (APPN) include a net purchase of 383,162 shares made by Abdiel Qualified Master Fund Lp , a net purchase of 10,010 shares made by Biddle Albert G.w. Iii , and a net sale of 700 shares made by William D. Mccarthy .

In summary, during the past 3 months, insiders sold 425,412 shares of Appian Corp (APPN) in total and bought 0 shares, with a net sale of 425,412 shares. During the past 18 months, 3,907,762 shares of Appian Corp (APPN) were sold and 4,300,234 shares were bought by its insiders, resulting in a net purchase of 392,472 shares.

Appian Corp (APPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Appian Corp Insider Transactions

No Available Data

What does Synlogic Inc do?

Who are the key executives at Synlogic Inc?

Scott D Sandell is the 10 percent owner of Synlogic Inc. Other key executives at Synlogic Inc include Chief Operating Officer Antoine Awad , Chief Financial Officer Michael Vangsted Jensen , and Chief Medical Officer Aoife Brennan .

Synlogic Inc (SYBX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Synlogic Inc (SYBX). Other recent insider transactions involving Synlogic Inc (SYBX) include a net sale of 2,518 shares made by , and a net sale of 372 shares made by Antoine Awad .

In summary, during the past 3 months, insiders sold 2,251 shares of Synlogic Inc (SYBX) in total and bought 0 shares, with a net sale of 2,251 shares. During the past 18 months, 2,890 shares of Synlogic Inc (SYBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,890 shares.

Synlogic Inc (SYBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synlogic Inc Insider Transactions

No Available Data

What does Strongbridge Biopharma PLC do?

Who are the key executives at Strongbridge Biopharma PLC?

Scott D Sandell is the 10 percent owner of Strongbridge Biopharma PLC. Other key executives at Strongbridge Biopharma PLC include 10 percent owner Cdk Associates, L.l.c. , 10 percent owner Caxton Corp , and 10 percent owner Bruce Kovner .

Strongbridge Biopharma PLC (SBBP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Strongbridge Biopharma PLC Insider Transactions

No Available Data

What does X4 Pharmaceuticals Inc do?

Who are the key executives at X4 Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of X4 Pharmaceuticals Inc. Other key executives at X4 Pharmaceuticals Inc include director & President and CEO Paula Ragan , Chief Commercial Officer Mark Baldry , and Chief Medical Officer Christophe Arbet-engels .

X4 Pharmaceuticals Inc (XFOR) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 690,513 shares made by Paula Ragan , a net sale of 179,382 shares made by Mary Dibiase , and a net sale of 616,284 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 0 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,707,983 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 35,050 shares were bought by its insiders, resulting in a net sale of 1,672,933 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

X4 Pharmaceuticals Inc Insider Transactions

No Available Data

What does Care.com Inc do?

Who are the key executives at Care.com Inc?

Scott D Sandell is the 10 percent owner of Care.com Inc. Other key executives at Care.com Inc include 10 percent owner Ac/interactivecorp , 10 percent owner Capitalg Gp Llc , and 10 percent owner Alphabet Inc. .

Care.com Inc (CRCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Care.com Inc (CRCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Care.com Inc (CRCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Care.com Inc (CRCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Care.com Inc Insider Transactions

No Available Data

What does Rhythm Pharmaceuticals Inc do?

Who are the key executives at Rhythm Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Rhythm Pharmaceuticals Inc. Other key executives at Rhythm Pharmaceuticals Inc include Chief Human Resources Officer Pamela J. Cramer , EVP & Head of International Yann Mazabraud , and Corporate Controller & CAO Christopher Paul German .

Rhythm Pharmaceuticals Inc (RYTM) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Rhythm Pharmaceuticals Inc (RYTM). Other recent insider transactions involving Rhythm Pharmaceuticals Inc (RYTM) include a net sale of 188,715 shares made by Joseph Shulman , a net sale of 141,432 shares made by Jennifer Chien , and a net sale of 107,577 shares made by Pamela J. Cramer .

In summary, during the past 3 months, insiders sold 155,744 shares of Rhythm Pharmaceuticals Inc (RYTM) in total and bought 0 shares, with a net sale of 155,744 shares. During the past 18 months, 807,890 shares of Rhythm Pharmaceuticals Inc (RYTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 807,890 shares.

Rhythm Pharmaceuticals Inc (RYTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rhythm Pharmaceuticals Inc Insider Transactions

No Available Data

What does Zosano Pharma Corp do?

Who are the key executives at Zosano Pharma Corp?

Scott D Sandell is the 10 percent owner of Zosano Pharma Corp. Other key executives at Zosano Pharma Corp include Chief Financial Officer Christine Matthews , director & Chief Executive Officer Steven Lo , and VP & Clinical Dev & Med Affairs Donald J Kellerman .

Zosano Pharma Corp (ZSANQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Zosano Pharma Corp (ZSANQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Zosano Pharma Corp (ZSANQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Zosano Pharma Corp (ZSANQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zosano Pharma Corp Insider Transactions

No Available Data

What does Achaogen Inc do?

Who are the key executives at Achaogen Inc?

Scott D Sandell is the 10 percent owner of Achaogen Inc. Other key executives at Achaogen Inc include 10 percent owner Robert W Duggan , Chief Operating Officer Elizabeth Bhatt , and See Remarks Gary Loeb .

Achaogen Inc (AKAOQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Achaogen Inc Insider Transactions

No Available Data

What does Sorrento Tech Inc do?

Who are the key executives at Sorrento Tech Inc?

Scott D Sandell is the 10 percent owner of Sorrento Tech Inc. Other key executives at Sorrento Tech Inc include 10 percent owner Orbimed Capital Gp Iii Llc , 10 percent owner Samuel D Isaly , and 10 percent owner Orbimed Advisors Llc .

Sorrento Tech Inc (ROKA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sorrento Tech Inc (ROKA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sorrento Tech Inc (ROKA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sorrento Tech Inc (ROKA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sorrento Tech Inc Insider Transactions

No Available Data

What does Interleukin Genetics Inc do?

Who are the key executives at Interleukin Genetics Inc?

Scott D Sandell is the 10 percent owner of Interleukin Genetics Inc. Other key executives at Interleukin Genetics Inc include 10 percent owner New Enterprise Associates 14, L.p. , 10 percent owner Growth Equity Opportunities Fund III, LLC , and Interim CFO Stephen J. Dipalma .

Interleukin Genetics Inc (ILIU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Interleukin Genetics Inc Insider Transactions

No Available Data

What does Opower Inc do?

Who are the key executives at Opower Inc?

Scott D Sandell is the 10 percent owner of Opower Inc. Other key executives at Opower Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner M James Barrett , and 10 percent owner Peter J Barris .

Opower Inc (OPWR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Opower Inc (OPWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Opower Inc (OPWR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Opower Inc (OPWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Opower Inc Insider Transactions

No Available Data

What does TriVascular Technologies Inc do?

Who are the key executives at TriVascular Technologies Inc?

Scott D Sandell is the 10 percent owner of TriVascular Technologies Inc. Other key executives at TriVascular Technologies Inc include 10 percent owner Krishna Kittu Kolluri , VP & Gen. Counsel and Secretary Kimberley A. Elting , and Chief Technology Officer Michael V. Chobotov .

TriVascular Technologies Inc (TRIV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of TriVascular Technologies Inc (TRIV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of TriVascular Technologies Inc (TRIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

TriVascular Technologies Inc (TRIV)'s detailed insider trading history can be found in Insider Trading Tracker table.

TriVascular Technologies Inc Insider Transactions

No Available Data

What does Epizyme Inc do?

Who are the key executives at Epizyme Inc?

Scott D Sandell is the 10 percent owner of Epizyme Inc. Other key executives at Epizyme Inc include Chief Scientific Officer Jeffery Kutok , Chief Operating Officer Jerald Korn , and Corporate Controller Joseph Beaulieu .

Epizyme Inc (EPZM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Epizyme Inc (EPZM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Epizyme Inc (EPZM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Epizyme Inc (EPZM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Epizyme Inc Insider Transactions

No Available Data

What does Supernus Pharmaceuticals Inc do?

Who are the key executives at Supernus Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Supernus Pharmaceuticals Inc. Other key executives at Supernus Pharmaceuticals Inc include SVP & Chief Medical Officer Jonathan Rubin , Sr. VP of IP & CSO Padmanabh P. Bhatt , and director & President & CEO Jack A. Khattar .

Supernus Pharmaceuticals Inc (SUPN) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Supernus Pharmaceuticals Inc (SUPN). Other recent insider transactions involving Supernus Pharmaceuticals Inc (SUPN) include a net sale of 132,750 shares made by Padmanabh P. Bhatt , a net sale of 38,886 shares made by Georges Gemayel , and a net sale of 250,000 shares made by Jack A. Khattar .

In summary, during the past 3 months, insiders sold 13,677 shares of Supernus Pharmaceuticals Inc (SUPN) in total and bought 0 shares, with a net sale of 13,677 shares. During the past 18 months, 477,688 shares of Supernus Pharmaceuticals Inc (SUPN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 477,688 shares.

Supernus Pharmaceuticals Inc (SUPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Supernus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avalo Therapeutics Inc do?

Who are the key executives at Avalo Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .

Avalo Therapeutics Inc (AVTX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 1,000 shares made by June Sherie Almenoff ,

In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Avalo Therapeutics Inc (AVTX) were sold and 1,000 shares were bought by its insiders, resulting in a net purchase of 1,000 shares.

Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avalo Therapeutics Inc Insider Transactions

No Available Data

What does Vitae Pharmaceuticals Inc do?

Who are the key executives at Vitae Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Vitae Pharmaceuticals Inc. Other key executives at Vitae Pharmaceuticals Inc include Chief Financial Officer Richard Steven Morris , General Counsel Scott Applebaum , and Chief Medical Officer Carole Sable .

Vitae Pharmaceuticals Inc (VTAE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vitae Pharmaceuticals Inc (VTAE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vitae Pharmaceuticals Inc (VTAE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vitae Pharmaceuticals Inc (VTAE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vitae Pharmaceuticals Inc Insider Transactions

No Available Data

What does Box Inc do?

Who are the key executives at Box Inc?

Scott D Sandell is the 10 percent owner of Box Inc. Other key executives at Box Inc include VP Chief Acct Ofr & Controller Eli Berkovitch , director & 10 percent owner & Chief Financial Officer Dylan C Smith , and director & 10 percent owner & Chief Executive Officer Aaron Levie .

Box Inc (BOX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Box Inc (BOX). Other recent insider transactions involving Box Inc (BOX) include a net sale of 234,000 shares made by Dylan C Smith , a net sale of 31,534 shares made by Eli Berkovitch , and a net sale of 60,000 shares made by Aaron Levie .

In summary, during the past 3 months, insiders sold 69,022 shares of Box Inc (BOX) in total and bought 0 shares, with a net sale of 69,022 shares. During the past 18 months, 730,118 shares of Box Inc (BOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 730,118 shares.

Box Inc (BOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Box Inc Insider Transactions

No Available Data

What does Boingo Wireless Inc do?

Who are the key executives at Boingo Wireless Inc?

Scott D Sandell is the 10 percent owner of Boingo Wireless Inc. Other key executives at Boingo Wireless Inc include Chief Technology Officer Derek Peterson , Chief Financial Officer Peter Hovenier , and Chief Marketing Officer Dawn Callahan .

Boingo Wireless Inc (WIFI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Boingo Wireless Inc (WIFI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Boingo Wireless Inc (WIFI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Boingo Wireless Inc (WIFI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Boingo Wireless Inc Insider Transactions

No Available Data

What does Trevena Inc do?

Who are the key executives at Trevena Inc?

Scott D Sandell is the 10 percent owner of Trevena Inc. Other key executives at Trevena Inc include SVP & Chief Medical Officer Mark Demitrack , SVP & Chief Business Officer Robert T Yoder , and director & President & CEO Carrie L. Bourdow .

Trevena Inc (TRVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Trevena Inc Insider Transactions

No Available Data

What does Tableau Software Inc do?

Who are the key executives at Tableau Software Inc?

Scott D Sandell is the director of Tableau Software Inc. Other key executives at Tableau Software Inc include EVP & GC & Secretary Keenan Michael Conder , EVP & Product Development Mark Thomas Nelson , and Executive VP & Sales Kelly Wright .

Tableau Software Inc (DATA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tableau Software Inc (DATA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tableau Software Inc (DATA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tableau Software Inc (DATA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tableau Software Inc Insider Transactions

No Available Data

What does Cvent Inc do?

Who are the key executives at Cvent Inc?

Scott D Sandell is the 10 percent owner of Cvent Inc. Other key executives at Cvent Inc include Chief Financial Officer Cynthia A Russo , 10 percent owner Insight Venture Partners Vii, L.p. , and 10 percent owner Insight Venture Partners (delaware) Vii, L.p. .

Cvent Inc (CVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cvent Inc (CVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cvent Inc (CVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cvent Inc (CVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cvent Inc Insider Transactions

No Available Data

What does Dermira Inc do?

Who are the key executives at Dermira Inc?

Scott D Sandell is the 10 percent owner of Dermira Inc. Other key executives at Dermira Inc include director & Chief Medical Officer Eugene A Bauer , director & CEO & Chairman of the Board Thomas G Wiggans , and CFO Andrew Guggenhime .

Dermira Inc (DERM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dermira Inc (DERM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dermira Inc (DERM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dermira Inc (DERM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dermira Inc Insider Transactions

No Available Data

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Loxo Oncology Inc do?

Who are the key executives at Loxo Oncology Inc?

Scott D Sandell is the 10 percent owner of Loxo Oncology Inc. Other key executives at Loxo Oncology Inc include Senior VP of Finance Jennifer Burstein , director & President & CEO Joshua H. Bilenker , and director & 10 percent owner Steve Elms .

Loxo Oncology Inc (LOXO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Loxo Oncology Inc (LOXO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Loxo Oncology Inc (LOXO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Loxo Oncology Inc (LOXO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Loxo Oncology Inc Insider Transactions

No Available Data

What does Aerohive Networks Inc do?

Who are the key executives at Aerohive Networks Inc?

Scott D Sandell is the 10 percent owner of Aerohive Networks Inc. Other key executives at Aerohive Networks Inc include VP & Gen. Counsel & Secretary Stephen Debenham , SVP & CFO & COO John Ritchie , and 10 percent owner Lightspeed General Partner Vii, L.p. .

Aerohive Networks Inc (HIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aerohive Networks Inc (HIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aerohive Networks Inc (HIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aerohive Networks Inc (HIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aerohive Networks Inc Insider Transactions

No Available Data

What does Workday Inc do?

Who are the key executives at Workday Inc?

Scott D Sandell is the director & 10 percent owner of Workday Inc. Other key executives at Workday Inc include 10 percent owner David A Duffield , Co-President Sayan Chakraborty , and EVP & General Counsel & Secty Richard Harry Sauer .

Workday Inc (WDAY) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Workday Inc (WDAY). Other recent insider transactions involving Workday Inc (WDAY) include a net sale of 2,997,679 shares made by David A Duffield , a net sale of 40,582 shares made by Sayan Chakraborty , and a net sale of 40,000 shares made by Still George J Jr .

In summary, during the past 3 months, insiders sold 396,661 shares of Workday Inc (WDAY) in total and bought 0 shares, with a net sale of 396,661 shares. During the past 18 months, 3,143,058 shares of Workday Inc (WDAY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,143,058 shares.

Workday Inc (WDAY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Workday Inc Insider Transactions

No Available Data

What does ChannelAdvisor Corp do?

Who are the key executives at ChannelAdvisor Corp?

Scott D Sandell is the 10 percent owner of ChannelAdvisor Corp. Other key executives at ChannelAdvisor Corp include director & Chief Executive Officer M Scot Wingo , Chief Operating Officer Elizabeth Segovia , and President and COO David J Spitz .

ChannelAdvisor Corp (ECOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChannelAdvisor Corp (ECOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChannelAdvisor Corp (ECOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChannelAdvisor Corp (ECOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChannelAdvisor Corp Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Scott D Sandell is the 10 percent owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Xoom Corp do?

Who are the key executives at Xoom Corp?

Scott D Sandell is the 10 percent owner of Xoom Corp. Other key executives at Xoom Corp include 10 percent owner Capital Xi Sequoia , 10 percent owner Sequoia Technology Partners Xi , and 10 percent owner Sequoia Capital Xi Principals Fund .

Xoom Corp (XOOM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Xoom Corp (XOOM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xoom Corp (XOOM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xoom Corp (XOOM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Xoom Corp Insider Transactions

No Available Data

What does Groupon Inc do?

Who are the key executives at Groupon Inc?

Scott D Sandell is the 10 percent owner of Groupon Inc. Other key executives at Groupon Inc include other: See Footnote 1 and Remarks Dusan Senkypl , Interim CAO Kyle Netzly , and Chief Financial Officer Jiri Ponrt .

Groupon Inc (GRPN) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Groupon Inc (GRPN). Other recent insider transactions involving Groupon Inc (GRPN) include a net purchase of 323,344 shares made by Dusan Senkypl , a net purchase of 15,000 shares made by Jason Harinstein , and a net sale of 4,583 shares made by Robert J Bass .

In summary, during the past 3 months, insiders sold 0 shares of Groupon Inc (GRPN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,583 shares of Groupon Inc (GRPN) were sold and 338,344 shares were bought by its insiders, resulting in a net purchase of 333,761 shares.

Groupon Inc (GRPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Groupon Inc Insider Transactions

No Available Data

What does Clovis Oncology Inc do?

Who are the key executives at Clovis Oncology Inc?

Scott D Sandell is the 10 percent owner of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .

Clovis Oncology Inc (CLVSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Clovis Oncology Inc Insider Transactions

No Available Data

What does Millennial Media Inc do?

Who are the key executives at Millennial Media Inc?

Scott D Sandell is the 10 percent owner of Millennial Media Inc. Other key executives at Millennial Media Inc include VP & Controller & Treasurer Lara Sweet , director & President Robert Lord , and 10 percent owner Verizon Communications Inc .

Millennial Media Inc (MM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millennial Media Inc (MM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millennial Media Inc (MM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millennial Media Inc (MM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Millennial Media Inc Insider Transactions

No Available Data

What does InnerWorkings Inc do?

Who are the key executives at InnerWorkings Inc?

Scott D Sandell is the 10 percent owner of InnerWorkings Inc. Other key executives at InnerWorkings Inc include director & President and CEO Richard S Stoddart , Chief Accounting Officer John Bosshart , and Executive VP and CFO Donald W Pearson .

InnerWorkings Inc (INWK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of InnerWorkings Inc (INWK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InnerWorkings Inc (INWK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

InnerWorkings Inc (INWK)'s detailed insider trading history can be found in Insider Trading Tracker table.

InnerWorkings Inc Insider Transactions

No Available Data

What does Amicus Therapeutics Inc do?

Who are the key executives at Amicus Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .

Amicus Therapeutics Inc (FOLD) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 150,869 shares made by Bradley L Campbell , a net sale of 266,751 shares made by John F Crowley , and a net sale of 95,000 shares made by Ellen Rosenberg .

In summary, during the past 3 months, insiders sold 400 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 400 shares. During the past 18 months, 618,495 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 618,495 shares.

Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amicus Therapeutics Inc Insider Transactions

No Available Data

What does Echo Global Logistics Inc do?

Who are the key executives at Echo Global Logistics Inc?

Scott D Sandell is the 10 percent owner of Echo Global Logistics Inc. Other key executives at Echo Global Logistics Inc include director & Chief Executive Officer Douglas R Waggoner , Chief Financial Officer David B Menzel , and Controller Douglas Hong .

Echo Global Logistics Inc (ECHO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Echo Global Logistics Inc (ECHO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Echo Global Logistics Inc (ECHO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Echo Global Logistics Inc (ECHO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Echo Global Logistics Inc Insider Transactions

No Available Data

What does Glu Mobile Inc do?

Who are the key executives at Glu Mobile Inc?

Scott D Sandell is the 10 percent owner of Glu Mobile Inc. Other key executives at Glu Mobile Inc include EVP & COO and CFO Eric R Ludwig , Senior Vice President & Revenue Becky Ann Hughes , and SVP & Business & Corp. Dev. Chris Akhavan .

Glu Mobile Inc (GLUU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Glu Mobile Inc (GLUU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Glu Mobile Inc (GLUU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Glu Mobile Inc (GLUU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Glu Mobile Inc Insider Transactions

No Available Data

What does Vonage Holdings Corp do?

Who are the key executives at Vonage Holdings Corp?

Scott D Sandell is the 10 percent owner of Vonage Holdings Corp. Other key executives at Vonage Holdings Corp include SVP Corporate Development Vinod Lala , Interim Chief Legal Officer Randy K. Rutherford , and director & Chief Executive Officer Rory P Read .

Vonage Holdings Corp (VG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Vonage Holdings Corp (VG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Vonage Holdings Corp (VG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Vonage Holdings Corp (VG)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vonage Holdings Corp Insider Transactions

No Available Data

What does ARYx Therapeutics Inc do?

Who are the key executives at ARYx Therapeutics Inc?

Scott D Sandell is the 10 percent owner of ARYx Therapeutics Inc. Other key executives at ARYx Therapeutics Inc include 10 percent owner Krishna Kittu Kolluri , 10 percent owner Growth Equity Opportunities Fund, Llc , and 10 percent owner Mark W Perry .

ARYx Therapeutics Inc (ARYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYx Therapeutics Inc (ARYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYx Therapeutics Inc (ARYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYx Therapeutics Inc (ARYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARYx Therapeutics Inc Insider Transactions

No Available Data

What does Voltari Corp do?

Who are the key executives at Voltari Corp?

Scott D Sandell is the 10 percent owner of Voltari Corp. Other key executives at Voltari Corp include 10 percent owner Carl C Icahn , Chief Financial Officer Nathan Yu-gai Fong , and SVP & Gen Counsel & Corp Sec Richard Jr Leigh .

Voltari Corp (VLTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Voltari Corp (VLTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Voltari Corp (VLTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Voltari Corp (VLTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Voltari Corp Insider Transactions

No Available Data

What does W World Corp do?

Who are the key executives at W World Corp?

Scott D Sandell is the 10 percent owner of W World Corp. Other key executives at W World Corp include director & 10 percent owner Anthony B Evnin , director & 10 percent owner Newhall Charles W Iii , and President and CFO Neill Sydney Colin .

W World Corp (WWHC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of W World Corp (WWHC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of W World Corp (WWHC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

W World Corp (WWHC)'s detailed insider trading history can be found in Insider Trading Tracker table.

W World Corp Insider Transactions

No Available Data

What does Inteliquent Inc do?

Who are the key executives at Inteliquent Inc?

Scott D Sandell is the 10 percent owner of Inteliquent Inc. Other key executives at Inteliquent Inc include director & President and CEO Matthew Jr Carter , Chief Financial Officer / EVP Kurt Abkemeier , and 10 percent owner C Richard Kramlich .

Inteliquent Inc (IQNT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inteliquent Inc (IQNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inteliquent Inc (IQNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inteliquent Inc (IQNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inteliquent Inc Insider Transactions

No Available Data

What does Paratek Pharmaceuticals Inc do?

Who are the key executives at Paratek Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Paratek Pharmaceuticals Inc. Other key executives at Paratek Pharmaceuticals Inc include CLO & General Counsel & Sec. William M. Haskel , President & Chief Commercial Adam Woodrow , and Chief Development & Regulatory Randall B. Brenner .

Paratek Pharmaceuticals Inc (PRTK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Paratek Pharmaceuticals Inc (PRTK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Paratek Pharmaceuticals Inc (PRTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Paratek Pharmaceuticals Inc (PRTK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Paratek Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

Scott D Sandell is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 7,125 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,125 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 92,875 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Savara Inc do?

Who are the key executives at Savara Inc?

Scott D Sandell is the 10 percent owner of Savara Inc. Other key executives at Savara Inc include Chief Financial Officer David L Lowrance , 10 percent owner Rick Yang , and 10 percent owner Forest Baskett .

Savara Inc (SVRA) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Savara Inc (SVRA). Other recent insider transactions involving Savara Inc (SVRA) include a net purchase of 250,000 shares made by David A Ramsay , a net sale of 138,702 shares made by Matthew Pauls , and a net sale of 35,000 shares made by David L Lowrance .

In summary, during the past 3 months, insiders sold 0 shares of Savara Inc (SVRA) in total and bought 150,000 shares, with a net purchase of 150,000 shares. During the past 18 months, 275,545 shares of Savara Inc (SVRA) were sold and 270,000 shares were bought by its insiders, resulting in a net sale of 5,545 shares.

Savara Inc (SVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Savara Inc Insider Transactions

No Available Data

What does CVRx Inc do?

Who are the key executives at CVRx Inc?

Scott D Sandell is the 10 percent owner of CVRx Inc. Other key executives at CVRx Inc include Chief Marketing Officer Paul Verrastro , 10 percent owner Johnson & Johnson , and 10 percent owner Johnson & Johnson Innovation - Jjdc, Inc. .

CVRx Inc (CVRX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in CVRx Inc (CVRX). Other recent insider transactions involving CVRx Inc (CVRX) include a net purchase of 8,500 shares made by Joseph P Slattery , a net sale of 3,975 shares made by Paul Verrastro , and a net purchase of 30,000 shares made by Kevin Hykes .

In summary, during the past 3 months, insiders sold 0 shares of CVRx Inc (CVRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,700 shares of CVRx Inc (CVRX) were sold and 38,500 shares were bought by its insiders, resulting in a net purchase of 30,800 shares.

CVRx Inc (CVRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

CVRx Inc Insider Transactions

No Available Data

What does Yumanity Therapeutics Inc do?

Who are the key executives at Yumanity Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .

Yumanity Therapeutics Inc (YMTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Yumanity Therapeutics Inc Insider Transactions

No Available Data

What does Minerva Surgical Inc do?

Who are the key executives at Minerva Surgical Inc?

Scott D Sandell is the 10 percent owner of Minerva Surgical Inc. Other key executives at Minerva Surgical Inc include 10 percent owner New Enterprise Associates 13 Lp , director & 10 percent owner Uri Geiger , and 10 percent owner Accelmed Partners Ii L.p. .

Minerva Surgical Inc (UTRS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Minerva Surgical Inc (UTRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Surgical Inc (UTRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Minerva Surgical Inc (UTRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Minerva Surgical Inc Insider Transactions

No Available Data

What does Tempest Therapeutics Inc do?

Who are the key executives at Tempest Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .

Tempest Therapeutics Inc (TPST) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .

In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 60,615 shares of Tempest Therapeutics Inc (TPST) were sold and 3,052 shares were bought by its insiders, resulting in a net sale of 57,564 shares.

Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tempest Therapeutics Inc Insider Transactions

No Available Data

What does Reneo Pharmaceuticals Inc do?

Who are the key executives at Reneo Pharmaceuticals Inc?

Scott D Sandell is the 10 percent owner of Reneo Pharmaceuticals Inc. Other key executives at Reneo Pharmaceuticals Inc include Chief Development Officer Ashley Hall , 10 percent owner Novo Holdings A/s , and Senior VP & Corporate Operation Michael Cruse .

Reneo Pharmaceuticals Inc (RPHM) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Reneo Pharmaceuticals Inc (RPHM). Other recent insider transactions involving Reneo Pharmaceuticals Inc (RPHM) include a net purchase of 1,199,482 shares made by Braden Michael Leonard ,

In summary, during the past 3 months, insiders sold 0 shares of Reneo Pharmaceuticals Inc (RPHM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Reneo Pharmaceuticals Inc (RPHM) were sold and 119,948 shares were bought by its insiders, resulting in a net purchase of 119,948 shares.

Reneo Pharmaceuticals Inc (RPHM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Reneo Pharmaceuticals Inc Insider Transactions

No Available Data

What does Coursera Inc do?

Who are the key executives at Coursera Inc?

Scott D Sandell is the director & 10 percent owner of Coursera Inc. Other key executives at Coursera Inc include SVP & General Counsel Alan B Cardenas , See Remarks Richard J Jacquet , and director & See Remarks Jeffrey Nacey Maggioncalda .

Coursera Inc (COUR) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Coursera Inc (COUR). Other recent insider transactions involving Coursera Inc (COUR) include a net sale of 1,160,001 shares made by Jeffrey Nacey Maggioncalda , a net sale of 593,692 shares made by Andrew Y. Ng , and a net sale of 263,785 shares made by Shravan Goli .

In summary, during the past 3 months, insiders sold 30,723 shares of Coursera Inc (COUR) in total and bought 0 shares, with a net sale of 30,723 shares. During the past 18 months, 2,413,957 shares of Coursera Inc (COUR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,413,957 shares.

Coursera Inc (COUR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Coursera Inc Insider Transactions

No Available Data

What does Verona Pharma PLC do?

Who are the key executives at Verona Pharma PLC?

Scott D Sandell is the 10 percent owner of Verona Pharma PLC. Other key executives at Verona Pharma PLC include Chief Medical Officer Kathleen A. Rickard , director & President and CEO David Zaccardelli , and Chief Financial Officer Mark W Hahn .

Verona Pharma PLC (VRNA) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Verona Pharma PLC (VRNA). Other recent insider transactions involving Verona Pharma PLC (VRNA) include a net sale of 2,800,000 shares made by Mark W Hahn , a net sale of 2,800,000 shares made by David Zaccardelli , and a net sale of 450,512 shares made by Kathleen A. Rickard .

In summary, during the past 3 months, insiders sold 79,264 shares of Verona Pharma PLC (VRNA) in total and bought 0 shares, with a net sale of 79,264 shares. During the past 18 months, 6,050,512 shares of Verona Pharma PLC (VRNA) were sold and 330,976 shares were bought by its insiders, resulting in a net sale of 5,719,536 shares.

Verona Pharma PLC (VRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Verona Pharma PLC Insider Transactions

No Available Data

What does NeueHealth Inc do?

Who are the key executives at NeueHealth Inc?

Scott D Sandell is the 10 percent owner of NeueHealth Inc. Other key executives at NeueHealth Inc include Chief Financial Officer Jay Matushak , director & CEO and President Mikan George Lawrence Iii , and GC & CORPORATE SECRETARY Jeff Michael Craig .

NeueHealth Inc (NEUE) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in NeueHealth Inc (NEUE). Other recent insider transactions involving NeueHealth Inc (NEUE) include a net sale of 198,867 shares made by Mikan George Lawrence Iii , a net sale of 18,858 shares made by Jay Matushak , and a net sale of 5,783 shares made by Jeffrey J Scherman .

In summary, during the past 3 months, insiders sold 120,194 shares of NeueHealth Inc (NEUE) in total and bought 0 shares, with a net sale of 120,194 shares. During the past 18 months, 243,283 shares of NeueHealth Inc (NEUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,283 shares.

NeueHealth Inc (NEUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

NeueHealth Inc Insider Transactions

No Available Data

What does Desktop Metal Inc do?

Who are the key executives at Desktop Metal Inc?

Scott D Sandell is the 10 percent owner of Desktop Metal Inc. Other key executives at Desktop Metal Inc include CHIEF OPERATING OFFICER Thomas Nogueira , CFO & TREASURER Jason M Cole , and Chief Technology Officer Jonah Myerberg .

Desktop Metal Inc (DM) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Desktop Metal Inc (DM). Other recent insider transactions involving Desktop Metal Inc (DM) include a net sale of 384,064 shares made by Jason M Cole , a net sale of 190,004 shares made by Jonah Myerberg , and a net sale of 7,298 shares made by Thomas Nogueira .

In summary, during the past 3 months, insiders sold 0 shares of Desktop Metal Inc (DM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 86,362 shares of Desktop Metal Inc (DM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,362 shares.

Desktop Metal Inc (DM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Desktop Metal Inc Insider Transactions

No Available Data

What does Robinhood Markets Inc do?

Who are the key executives at Robinhood Markets Inc?

Scott D Sandell is the director & 10 percent owner of Robinhood Markets Inc. Other key executives at Robinhood Markets Inc include director & 10 percent owner & Chief Creative Officer Baiju Bhatt , Chief Legal Officer Gallagher Daniel Martin Jr , and director & 10 percent owner & Chief Executive Officer Vladimir Tenev .

Robinhood Markets Inc (HOOD) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Robinhood Markets Inc (HOOD). Other recent insider transactions involving Robinhood Markets Inc (HOOD) include a net sale of 4,453,532 shares made by Baiju Bhatt , a net sale of 5,407,797 shares made by Vladimir Tenev , and a net sale of 731,177 shares made by Gallagher Daniel Martin Jr .

In summary, during the past 3 months, insiders sold 2,418,010 shares of Robinhood Markets Inc (HOOD) in total and bought 0 shares, with a net sale of 2,418,010 shares. During the past 18 months, 25,233,608 shares of Robinhood Markets Inc (HOOD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,233,608 shares.

Robinhood Markets Inc (HOOD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Robinhood Markets Inc Insider Transactions

No Available Data

What does Arcellx Inc do?

Who are the key executives at Arcellx Inc?

Scott D Sandell is the 10 percent owner of Arcellx Inc. Other key executives at Arcellx Inc include director & See Remarks Rami Elghandour , Chief Medical Officer Christopher Heery , and Chief Financial Officer Michelle Gilson .

Arcellx Inc (ACLX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Arcellx Inc (ACLX). Other recent insider transactions involving Arcellx Inc (ACLX) include a net sale of 373,662 shares made by Christopher Heery , a net sale of 88,479 shares made by Kavita Patel , and a net sale of 109,308 shares made by Michelle Gilson .

In summary, during the past 3 months, insiders sold 54,455 shares of Arcellx Inc (ACLX) in total and bought 0 shares, with a net sale of 54,455 shares. During the past 18 months, 1,816,068 shares of Arcellx Inc (ACLX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,816,068 shares.

Arcellx Inc (ACLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcellx Inc Insider Transactions

No Available Data

What does Berkshire Grey Inc do?

Who are the key executives at Berkshire Grey Inc?

Scott D Sandell is the 10 percent owner of Berkshire Grey Inc. Other key executives at Berkshire Grey Inc include 10 percent owner Svf Ii Bg (de) Llc , 10 percent owner Softbank Group Corp , and director & Chief Executive Officer Thomas Anderson Wagner .

Berkshire Grey Inc (BGRY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Berkshire Grey Inc (BGRY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Berkshire Grey Inc (BGRY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Berkshire Grey Inc (BGRY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Berkshire Grey Inc Insider Transactions

No Available Data

What does IonQ Inc do?

Who are the key executives at IonQ Inc?

Scott D Sandell is the 10 percent owner of IonQ Inc. Other key executives at IonQ Inc include Chief Revenue Officer Rima Alameddine , director & President and CEO Peter Hume Chapman , and Chief Financial Officer Thomas G. Kramer .

IonQ Inc (IONQ) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in IonQ Inc (IONQ). Other recent insider transactions involving IonQ Inc (IONQ) include a net sale of 248,439 shares made by Rima Alameddine , a net sale of 4,134,543 shares made by Peter Hume Chapman , and a net sale of 87,679 shares made by Thomas G. Kramer .

In summary, during the past 3 months, insiders sold 4,045,235 shares of IonQ Inc (IONQ) in total and bought 93,066 shares, with a net sale of 3,952,169 shares. During the past 18 months, 4,505,433 shares of IonQ Inc (IONQ) were sold and 208,071 shares were bought by its insiders, resulting in a net sale of 4,297,362 shares.

IonQ Inc (IONQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

IonQ Inc Insider Transactions

No Available Data

What does Monte Rosa Therapeutics Inc do?

Who are the key executives at Monte Rosa Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , Principal Accounting Officer Edmund Dunn , and General Counsel Philip Nickson .

Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , a net sale of 2,817 shares made by Edmund Dunn , and a net purchase of 10,000 shares made by Chandra P. Leo .

In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 1,860,491 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 1,850,491 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Monte Rosa Therapeutics Inc Insider Transactions

No Available Data

What does BuzzFeed Inc do?

Who are the key executives at BuzzFeed Inc?

Scott D Sandell is the 10 percent owner of BuzzFeed Inc. Other key executives at BuzzFeed Inc include 10 percent owner New Enterprise Associates 13 Lp , other: Member of 10% Group Johnson John S. Iii , and 10 percent owner Comcast Corp .

BuzzFeed Inc (BZFD) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in BuzzFeed Inc (BZFD). Other recent insider transactions involving BuzzFeed Inc (BZFD) include a net sale of 229,000 shares made by Johnson John S. Iii , a net sale of 431,974 shares made by New Enterprise Associates 13 Lp , and a net sale of 431,974 shares made by Patrick J Kerins .

In summary, during the past 3 months, insiders sold 863,948 shares of BuzzFeed Inc (BZFD) in total and bought 0 shares, with a net sale of 863,948 shares. During the past 18 months, 4,206,922 shares of BuzzFeed Inc (BZFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,206,922 shares.

BuzzFeed Inc (BZFD)'s detailed insider trading history can be found in Insider Trading Tracker table.

BuzzFeed Inc Insider Transactions

No Available Data

What does Senti Biosciences Inc do?

Who are the key executives at Senti Biosciences Inc?

Scott D Sandell is the 10 percent owner of Senti Biosciences Inc. Other key executives at Senti Biosciences Inc include director & CEO and President Timothy K Lu , Chief Medical & Devt. Officer Kanya Rajangam , and Chief Operating Officer Herberts Curt A. Iii .

Senti Biosciences Inc (SNTI) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Senti Biosciences Inc (SNTI). Other recent insider transactions involving Senti Biosciences Inc (SNTI) include a net sale of 4,467 shares made by Timothy K Lu , and a net sale of 1,479 shares made by Kanya Rajangam .

In summary, during the past 3 months, insiders sold 5,946 shares of Senti Biosciences Inc (SNTI) in total and bought 0 shares, with a net sale of 5,946 shares. During the past 18 months, 5,946 shares of Senti Biosciences Inc (SNTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,946 shares.

Senti Biosciences Inc (SNTI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Senti Biosciences Inc Insider Transactions

No Available Data

What does ZeroFox Holdings Inc do?

Who are the key executives at ZeroFox Holdings Inc?

Scott D Sandell is the 10 percent owner of ZeroFox Holdings Inc. Other key executives at ZeroFox Holdings Inc include director & See Remarks James Christopher Foster , Chief Marketing Officer Prestridge Iii John R , and Chief Technology Officer Michael Morgan Price .

ZeroFox Holdings Inc (ZFOX) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in ZeroFox Holdings Inc (ZFOX). Other recent insider transactions involving ZeroFox Holdings Inc (ZFOX) include a net sale of 80,542 shares made by James Christopher Foster , a net sale of 31,736 shares made by Timothy S Bender , and a net sale of 29,014 shares made by Michael Morgan Price .

In summary, during the past 3 months, insiders sold 0 shares of ZeroFox Holdings Inc (ZFOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 232,200 shares of ZeroFox Holdings Inc (ZFOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 232,200 shares.

ZeroFox Holdings Inc (ZFOX)'s detailed insider trading history can be found in Insider Trading Tracker table.

ZeroFox Holdings Inc Insider Transactions

No Available Data

What does Kineta Inc do?

Who are the key executives at Kineta Inc?

Scott D Sandell is the 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .

Kineta Inc (KANT) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Kineta Inc (KANT). Other recent insider transactions involving Kineta Inc (KANT) include a net purchase of 5,000 shares made by Shawn Iadonato , a net purchase of 3,000 shares made by Craig W. Philips , and a net purchase of 2,250 shares made by Raymond J. Bartoszek .

In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KANT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kineta Inc (KANT) were sold and 10,250 shares were bought by its insiders, resulting in a net purchase of 10,250 shares.

Kineta Inc (KANT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kineta Inc Insider Transactions

No Available Data

What does Enliven Therapeutics Inc do?

Who are the key executives at Enliven Therapeutics Inc?

Scott D Sandell is the 10 percent owner of Enliven Therapeutics Inc. Other key executives at Enliven Therapeutics Inc include director & Chief Scientific Officer Joseph P Lyssikatos , director & President and CEO Samuel Kintz , and Chief Operating Officer Anish Patel .

Enliven Therapeutics Inc (ELVN) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Enliven Therapeutics Inc (ELVN). Other recent insider transactions involving Enliven Therapeutics Inc (ELVN) include a net sale of 110,564 shares made by Benjamin Hohl , a net sale of 245,842 shares made by Samuel Kintz , and a net sale of 245,347 shares made by Joseph P Lyssikatos .

In summary, during the past 3 months, insiders sold 63,501 shares of Enliven Therapeutics Inc (ELVN) in total and bought 0 shares, with a net sale of 63,501 shares. During the past 18 months, 4,299,827 shares of Enliven Therapeutics Inc (ELVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,299,827 shares.

Enliven Therapeutics Inc (ELVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Enliven Therapeutics Inc Insider Transactions

No Available Data

What does Genocea Biosciences Inc do?

Who are the key executives at Genocea Biosciences Inc?

Scott D Sandell is the 10 percent owner of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , EVP PHARM SCI & MFG Stapleton Raymond D Jr , and 10 percent owner Paul Edward Walker .

Genocea Biosciences Inc (GGNNQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Genocea Biosciences Inc Insider Transactions

No Available Data

What does Sagimet Biosciences Inc do?

Who are the key executives at Sagimet Biosciences Inc?

Scott D Sandell is the 10 percent owner of Sagimet Biosciences Inc. Other key executives at Sagimet Biosciences Inc include General Counsel and CCO Elizabeth Rozek , director & President & CEO David Happel , and 10 percent owner New Enterprise Associates 13 Lp .

Sagimet Biosciences Inc (SGMT) Insider Trades Summary

Over the past 18 months, Scott D Sandell made no insider transaction in Sagimet Biosciences Inc (SGMT). Other recent insider transactions involving Sagimet Biosciences Inc (SGMT) include a net purchase of 14,290 shares made by David Happel , a net sale of 37,687 shares made by George Kemble , and a net sale of 10,914 shares made by Elizabeth Rozek .

In summary, during the past 3 months, insiders sold 0 shares of Sagimet Biosciences Inc (SGMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 56,958 shares of Sagimet Biosciences Inc (SGMT) were sold and 14,290 shares were bought by its insiders, resulting in a net sale of 42,668 shares.

Sagimet Biosciences Inc (SGMT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sagimet Biosciences Inc Insider Transactions

No Available Data

What does Revolution Acceleration Acquisition Corp do?

Who are the key executives at Revolution Acceleration Acquisition Corp?

Scott D Sandell is the 10 percent owner of Revolution Acceleration Acquisition Corp. Other key executives at Revolution Acceleration Acquisition Corp include 10 percent owner Softbank Group Corp , director & Chief Executive Officer Thomas Anderson Wagner , and See Remarks Steven Jay Johnson .

Revolution Acceleration Acquisition Corp (RAACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Revolution Acceleration Acquisition Corp (RAACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Acceleration Acquisition Corp (RAACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Acceleration Acquisition Corp (RAACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revolution Acceleration Acquisition Corp Insider Transactions

No Available Data

What does Korro Bio Inc do?

Who are the key executives at Korro Bio Inc?

Scott D Sandell is the 10 percent owner of Korro Bio Inc. Other key executives at Korro Bio Inc include Chief Financial Officer Vineet Agarwal , 10 percent owner Forest Baskett , and 10 percent owner New Enterprise Associates 17, L.p. .

Korro Bio Inc (KRRO) Insider Trades Summary

Over the past 18 months, Scott D Sandell made 1 insider transaction in Korro Bio Inc (KRRO) with a net purchase of 17,857. Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 11,016 shares made by Vineet Agarwal , a net sale of 2,124 shares made by David L. Lucchino , and a net purchase of 17,857 shares made by Rick Yang .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,140 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 165,430 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Korro Bio Inc Insider Transactions

No Available Data

Scott D Sandell Mailing Address

Above is the net worth, insider trading, and ownership report for Scott D Sandell. Currently GuruFocus does not have mailing address information for Scott D Sandell.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.